Development and Manufacturing of Aluminum Adjuvanted Vaccines

This technical report discusses the development and manufacturing processes of vaccines that contain aluminum adjuvants. It outlines the benefits of aluminum salts in enhancing the potency and immunogenicity of vaccines, as well as the unique challenges faced by manufacturers in this area. Key challenges include filterability issues due to the particle sizes of aluminum adjuvants, packaging constraints, and the handling of gel suspensions. The report details how Resilience, a biomanufacturing company, addresses these challenges through specialized manufacturing environments and equipment, such as closed systems and aseptic processes. It also highlights Resilience's capabilities in scaling up vaccine production and its collaborative approach with industry stakeholders to support vaccine development. The report emphasizes the importance of expertise in the formulation process and the need for established procedures to ensure the successful manufacturing of alum-containing vaccines.